Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop selling off-brand versions of the weight-loss drugs. The FDA has issued warnings against the off-brand versions, citing safety concerns.
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with sleep apnea and obesity, the drugmaker said after the bell Friday.Trials of the Lilly drug found that it helped reduce the number of breathing disruptions in an average night of sleep.
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for these medications.
Popular Weight Loss Drug Zepbound Gains FDA Approval to Treat Sleep Apnea
The FDA has approved Eli Lilly's Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity.
FDA approves Zepbound for sleep apnea treatment
ABC News' Dr. Darien Sutton breaks down the FDA’s approval of the popular weight loss medication for the treatment of obstructive sleep apnea in adults with obesity.
This Popular Weight Loss Drug Can Now Be Used To Treat Sleep Apnea
Zepbound is the first medication approved to treat people with obstructive sleep apnea, said Sailly Seymor, director of FDA's division of pulmonology, allergy, and critical care.
Mushrooms, pizza and more items recalled by the FDA. Here's the list for December 2024
FDA receives reports almost daily from different food companies regarding potential allergens or foodborne illnesses.
Shooting the Messenger and Blaming the Victim
The post Shooting the Messenger and Blaming the Victim appeared first on Reason.com. Just before 9 p.m. on Thursday, Dec. 19, ...
McKnight's Long-Term Care News22h
FDA updates meaning of ‘healthy’ on food labels
The US Food and Drug Administration wants to redefine the meaning of healthy food, issuing a new rule Thursday that changes ...
JD Supra8h
Food and Beverage Litigation and Regulatory Update - December 2024
The U.S. Food and Drug Administration (FDA) has announced a final rule updating the definition of the nutrient content claim “healthy.” To qualify ...
Indies Pharma looks to earn from FDA-approved drug next year
Following the recent approval of its Regadenoson generic drug by the United States Food and Drug Administration (FDA), Indies ...
FDA approves anti-obesity drug as first sleep apnea medication
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
Merck to discontinue drug for bacterial infection
Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug ...
FDA says shortage of GLP-1 drug tirzepatide is over
The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...
Medscape19h
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
US FDA approves Hikma's generic version of Novo's diabetes drug Victoza
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
Peninsula drugmaker lands $150 million, food allergy drug to fill pipeline hole
If your drug trials don't succeed, try again with another drug — and raise more money. That's $RAPT's plan as it targets food ...